Association of Circulating Caprylic Acid with Risk of Mild Cognitive Impairment and Alzheimer's Disease in the Alzheimer's Disease Neuroimaging Initiative (ADNI) Cohort
Authors:
Open Access
- 31 March 2023
- journal article
- research article
- Published by Elsevier in The Journal Of Prevention of Alzheimer's Disease
- Vol. 10 (3) , 513-522
Abstract
Medium-chain fatty acids (MCFAs) can rapidly cross the blood-brain barrier and provide an alternative energy source for the brain. This study aims to deterKeywords
This publication has 70 references indexed in Scilit:
- Retrospective case studies of the efficacy of caprylic triglyceride in mild-to-moderate Alzheimer's diseaseNeuropsychiatric Disease and Treatment, 2013
- Caprylic Triglyceride as a Novel Therapeutic Approach to Effectively Improve the Performance and Attenuate the Symptoms Due to the Motor Neuron Loss in ALS DiseasePLOS ONE, 2012
- How does diabetes accelerate Alzheimer disease pathology?Nature Reviews Neurology, 2010
- The Role of Metabolic Disorders in Alzheimer Disease and Vascular DementiaArchives of Neurology, 2009
- Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trialNutrition & Metabolism, 2009
- Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic dietAnnals of Neurology, 2006
- Fuel Metabolism in StarvationAnnual Review of Nutrition, 2006
- Ketone Bodies, Potential Therapeutic UsesIUBMB Life, 2001
- Flexible regression models with cubic splinesStatistics in Medicine, 1989
- Chronic ketosis and cerebral metabolismAnnals of Neurology, 1978